M Cremonesi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M Cremonesi

Showing results (31-40 of 280) with videos related to

Pageof 28

Sort By:

Cancer Biotherapy & Radiopharmaceuticals|July 27, 2001

Pre-targeted locoregional radioimmunotherapy with 90Y-biotin in glioma patients: phase I study and preliminary therapeutic resultsG Paganelli, M Bartolomei, M Ferrari, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 29, 2009

Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trialM Mandalà, S Barni, M Prins, et al.

Nuclear Medicine Communications|October 21, 1999

Radiation protection in radioguided surgery of breast cancerM Cremonesi, M Ferrari, E Sacco, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004

Safety of sentinel node biopsy in pregnant patients with breast cancerO Gentilini, M Cremonesi, G Trifirò, et al.

European Journal of Nuclear Medicine|August 7, 1999

Biokinetics and dosimetry in patients administered with (111)In-DOTA-Tyr(3)-octreotide: implications for internal radiotherapy with (90)Y-DOTATOCM Cremonesi, M Ferrari, S Zoboli, et al.

European Journal of Nuclear Medicine|May 19, 2001

Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotideG Paganelli, S Zoboli, M Cremonesi, et al.

European Journal of Nuclear Medicine|April 13, 1999

Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotinG Paganelli, C Grana, M Chinol, et al.

British Journal of Cancer|July 31, 1998

Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicityM Chinol, P Casalini, M Maggiolo, et al.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 20, 2010

Dosimetry for treatment with radiolabelled somatostatin analogues. A reviewM Cremonesi, F Botta, A Di Dia, et al.

Biomed Research International|July 19, 2013

Kidney dosimetry in ¹⁷⁷Lu and ⁹⁰Y peptide receptor radionuclide therapy: influence of image timing, time-activity integration method, and risk factorsF Guerriero, M E Ferrari, F Botta, et al.

Pageof 28

Search research articles

Showing results (31-40 of 280) with videos related to